NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

Sharps Technology, Inc. (STSS) Stock Analysis

Sharps Technology, Inc. (STSS) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

STSS

$1.15

−$0.67 (−36.81%)

Last trade July 17, 2026

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare STSS with… →

STSS Key Statistics

As of Jul 17, 2026
Trading
Open
$1.15
Previous Close
$1.82
Day's Range
1.11–1.21
52-Week Range
1.42–18.23
Volume
112.63K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.02
Valuation
Market Cap
$77.03M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
21.81
EPS (ttm)Profit attributable to each share over the last twelve months.
−64.49
Financials (FY)
Revenue (FY)
$204.12K
Net Income (FY)
−$282.50M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
1-Year Return
−80.21%
Dividend and dates
Avg Volume
316.56K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

STSS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−43.35%
2025−99.67%
2024 (partial year)+8.99%

As of July 17, 2026.

STSS Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$204.12K−$282.50M−138400.0%
2024$0.00−$9.30M—
2023$0.00−$9.84M—
2022$0.00−$4.64M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$204.12K−$413.33K−$13.29M−$282.50M−138400.0%
2024$0.00$0.00−$5.57M−$9.30M—
2023$0.00—−$10.13M−$9.84M—
2022$0.00—−$8.74M−$4.64M—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

STSS Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricSTSSMedical Instruments & Supplies medianvs median
P/S ratio21.813.176.9x the median
Profit margin0.00%0.85%0.8 pts below

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Sharps Technology, Inc. (STSS) carries a market capitalisation of $77.03M. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector.

The 52-week range on file runs from $1.42 to $18.23. The most recent close on file for STSS is $1.15, dated July 17, 2026. That is −$0.67 (−36.81%) against the previous close.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $204.12K. The same year closed with a net loss of $282.50M. The reported profit margin is 0%. That is 0.8 percentage points below the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to −64.49.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $204.12K in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 21.81. On price-to-sales that is 6.9 times the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned −80.21%. The stored price history starts on December 19, 2024, and the total return since then is −99.80%. The reported beta is 2.02. Daily returns over the trailing 1 year annualize to a volatility of 134.26%.

Growth & Income

The record shows no dividend for STSS.

So far in 2026 the price is −43.35%. The record holds one complete calendar year, 2025, which returned −99.67%.

Peer Comparison

Sharps Technology, Inc. (STSS) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Sharps Technology, Inc. STSS $77.03M —
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Sharps Technology, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of July 17, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Sharps Technology, Inc.

Sharps Technology, Inc. engages in the marketing and distribution of syringe products and related drug-delivery systems in the United States and internationally. The company operates in two segments, Medical Device Packaging and Digital Asset Treasury. It distributes and markets safety syringes under the SecureGard, SoloGard, and Provensa brands; prefillable polymer syringes; and pharmaceutical services. The company also engages in executing and managing its treasury platform, which focuses on accumulating Solana. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

Visit website →